- CME Group (CME, Financial) experiences record-breaking trading activity in Q2 2025.
- Wall Street analysts offer varied price targets with a consensus "Hold" recommendation.
- GuruFocus GF Value indicates a potential downside for CME shares.
CME Group (CME) recently reported an impressive performance for Q2 2025, showcasing its prowess in the trading arena. The quarter marked a significant milestone with an average daily volume (ADV) of 30.2 million contracts, reflecting a robust 15% increase compared to the prior year. The month of June was particularly noteworthy, achieving a record ADV of 25.7 million contracts. This surge was fueled by heightened activity in interest rate, agricultural, and metals products, highlighting the diverse trading interests that power CME's growth.
Wall Street Analysts' Price Targets
In terms of future prospects, Wall Street analysts have offered mixed one-year price targets for CME Group Inc (CME, Financial). The average target price stands at $278.67, with projections ranging from a high of $305.00 to a low of $225.00. This average target suggests a modest upside of 2.07% from the current trading price of $273.01. For a deeper dive into these projections, you can explore the detailed estimate data on the CME Group Inc (CME) Forecast page.
Analyst Recommendations: A "Hold" Consensus
The consensus among 18 brokerage firms provides a nuanced picture of CME Group Inc's (CME, Financial) investment potential. With an average brokerage recommendation of 2.6, the stock is currently pegged at a "Hold" status. This rating is devised on a scale from 1 to 5, where 1 denotes a "Strong Buy" and 5 signifies a "Sell."
Understanding GuruFocus GF Value Estimation
According to GuruFocus estimates, the GF Value for CME Group Inc (CME, Financial) anticipated in one year is $258.64, indicating a potential downside of 5.26% from its current price of $273.01. The GF Value represents GuruFocus' calculated fair value based on historical trading multiples, business growth, and future performance estimates. Investors seeking comprehensive insights can access detailed data on the CME Group Inc (CME) Summary page.
